Historical shareholding details of
UBS O'Connor LLC
holdings in Keros Therapeutics Inc (KROS)
Monthly changes of
UBS O'Connor LLC
shareholding in Keros Therapeutics Inc
over the previous
months
|
Month
|
Name |
Total no. shares held |
Percent Holding |
|
Jun 30, 2025
|
Ubs O'Connor Llc
|
37,891
|
0.09%
|
|
|
|
Mar 31, 2025
|
Ubs O'Connor Llc
|
115,518
|
0.28%
|
|
|
|
Dec 31, 2024
|
Ubs O'Connor Llc
|
50,897
|
0.13%
|
|
|
|
Sep 30, 2024
|
Ubs O'Connor Llc
|
24,752
|
0.06%
|
|
|
|
Jun 30, 2024
|
Ubs O'Connor Llc
|
22,453
|
0.06%
|
|
|
|
Mar 31, 2024
|
Ubs O'Connor Llc
|
17,053
|
0.05%
|
|
|
|
Dec 31, 2023
|
Ubs O'Connor Llc
|
14,112
|
0.04%
|
|
|
|
Sep 30, 2023
|
Ubs O'Connor Llc
|
60,341
|
0.20%
|
|
|
|
Jun 30, 2023
|
Ubs O'Connor Llc
|
55,341
|
0.19%
|
|
|
|
Mar 31, 2023
|
Ubs O'Connor Llc
|
45,484
|
0.15%
|
|
|
|
Dec 31, 2022
|
Ubs O'Connor Llc
|
45,318
|
0.15%
|
View all ownership details of Keros Therapeutics Inc